Plerixafor octahydrochloride
Cat. No.:YN321289
| 产品名称: | Plerixafor octahydrochloride | 
| CAS No.: | 155148-31-5 | 
| Chemical Name: | 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane Hydrochloride (1:8); 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane Octahydrochloride; AMD 3100; JM 3100; SID 791; | 
| Synonyms: | 盐酸普乐沙福; AMD3100 octahydrochloride; JM3100 octahydrochloride; SID791 octahydrochloride | 
| 分子量: | 794.47 | 
| 分子式: | C₂₈H₆₂Cl₈N₈ | 
| SMILES: | [H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.N1(CCCNCCNCCCNCC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3 | 
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. | 
| 运输: | Room temperature in continental US; may vary elsewhere. | 
| 产品描述: | Plerixafor octahydrochloride (AMD3100 octahydrochloride) 是一种选择性的CXCR4拮抗剂,IC50为 44 nM。 | 
| IC50和靶点: | [{name:"125I-CXCL12-CXCR4:44 nM (IC50)'}, '125I-CXCL12-CXCR7', {'HIV-1:1-10 nM (EC50)"},{name: "HIV-2:1-10 nM (EC50)"}] | 
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: | 
Xie, T., et al.: Science, 290, 328 (2000), Leone, D., et al.: J. Pharmacol. Exp. Ther., 305, 1150 (2003),